Your browser doesn't support javascript.
loading
Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation.
García-Nicolás, O; Godel, A; Zimmer, G; Summerfield, A.
Afiliação
  • García-Nicolás O; Institute of Virology and Immunology (IVI), Sensemattstrasse 293, 3147, Mittelhäusern, Switzerland. obdulio.garcia-nicolas@ivi.admin.ch.
  • Godel A; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. obdulio.garcia-nicolas@ivi.admin.ch.
  • Zimmer G; Multidisciplinary Center for Infectious Diseases, University of Bern, Bern, Switzerland. obdulio.garcia-nicolas@ivi.admin.ch.
  • Summerfield A; Institute of Virology and Immunology (IVI), Sensemattstrasse 293, 3147, Mittelhäusern, Switzerland.
Cell Mol Immunol ; 20(7): 835-849, 2023 07.
Article em En | MEDLINE | ID: mdl-37253946
ABSTRACT
Early and strong interferon type I (IFN-I) responses are usually associated with mild COVID-19 disease, whereas persistent or unregulated proinflammatory cytokine responses are associated with severe disease outcomes. Previous work suggested that monocyte-derived macrophages (MDMs) are resistant and unresponsive to SARS-CoV-2 infection. Here, we demonstrate that upon phagocytosis of SARS-CoV-2-infected cells, MDMs are activated and secrete IL-6 and TNF. Importantly, activated MDMs in turn mediate strong activation of plasmacytoid dendritic cells (pDCs), leading to the secretion of high levels of IFN-α and TNF. Furthermore, pDC activation promoted IL-6 production by MDMs. This kind of pDC activation was dependent on direct integrin-mediated cell‒cell contacts and involved stimulation of the TLR7 and STING signaling pathways. Overall, the present study describes a novel and potent pathway of pDC activation that is linked to the macrophage-mediated clearance of infected cells. These findings suggest that a high infection rate by SARS-CoV-2 may lead to exaggerated cytokine responses, which may contribute to tissue damage and severe disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / COVID-19 Limite: Humans Idioma: En Revista: Cell Mol Immunol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / COVID-19 Limite: Humans Idioma: En Revista: Cell Mol Immunol Ano de publicação: 2023 Tipo de documento: Article